Family History Study of Alcohol Consumption Using Memantine
NCT ID: NCT00630955
Last Updated: 2020-03-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
111 participants
INTERVENTIONAL
2006-06-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Placebo-Controlled Trial of Memantine for Alcohol Dependence
NCT00246415
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control
NCT02949934
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
NCT01519063
Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
NCT00563797
Ketamine/Placebo Family History Positive Study
NCT00588952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
20 mg memantine
memantine
Memantine 20 mg once per day for 7 days
2
40 mg memantine
Memantine
Memantine 40 mg once per day for 7 days
3
Placebo
Placebo once per day for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
memantine
Memantine 20 mg once per day for 7 days
Memantine
Memantine 40 mg once per day for 7 days
Placebo
Placebo once per day for 7 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read English at 6th grade level or higher and to complete study evaluations
* Regular alcohol drinker
Exclusion Criteria
* Medical conditions that would contraindicate the use of memantine
* Regular use of other substances
21 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suchitra Krishnan-Sarin, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMHC
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0602001068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.